We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Recommends Early-Stage Clinical Trials for Certain Type 2 Diabetes Devices
FDA Recommends Early-Stage Clinical Trials for Certain Type 2 Diabetes Devices
Developers of devices that are intended to improve glycemic control in patients with type 2 diabetes should conduct an early-stage feasibility and safety study to support additional trials that further hone in on feasibility, the FDA said in a final guidance.